HAMAD MEDICAL CORPORATION
🇶🇦Qatar
Qatar Cardiometabolic Registry
Recruiting
- Conditions
- Diabetes MellitusCardiovascular Diseases
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 50000
- Registration Number
- NCT03394313
- Locations
- 🇶🇦
Hamad Medical Coorporation, Doha, Qatar
Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock
Phase 2
Terminated
- Conditions
- Septic ShockCritical Illness
- Interventions
- Drug: Triple therapy group
- First Posted Date
- 2017-12-21
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 106
- Registration Number
- NCT03380507
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
The Recurrence Study
Not Applicable
- Conditions
- Acute StrokeTransient Ischemic Attack
- Interventions
- Diagnostic Test: Corneal Confocal ImagingDiagnostic Test: Magnetic resonance ImagingOther: Blood sample
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2017-08-09
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT03244215
- Locations
- 🇶🇦
The Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar
An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes
- First Posted Date
- 2017-07-13
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 320
- Registration Number
- NCT03216564
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Protein Supplementation Impact On Body Muscle Mass And Fat Mass In Qataris Post Bariatric Surgery, Randomized Controlled Trials (Rct)
Not Applicable
- Conditions
- Obesity
- Interventions
- Dietary Supplement: (Cubitan Protein, Nutricia, Netherlands).Dietary Supplement: (preOp, Nutricia, Netherlands).
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT03147456
- Locations
- 🇶🇦
sahar Dahawi Alshamari, Doha, Qatar
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
Withdrawn
- Conditions
- LymphomaAcute Lymphoblastic LeukemiaIron OverloadHemoglobinopathies
- Interventions
- Diagnostic Test: Continuous Glucose Monitoring (CGM)Diagnostic Test: Oral Glucose Tolerance Test (OGTT)Diagnostic Test: T2* MRI of the Pancreas
- First Posted Date
- 2017-05-05
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Hamad Medical Corporation
- Registration Number
- NCT03141398
18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms
Not Applicable
Terminated
- Conditions
- Essential ThrombocythemiaPrimary Myelofibrosis, Fibrotic StagePrimary Myelofibrosis, Prefibrotic StagePolycythemia Vera
- Interventions
- Device: Diagnostic (18F-FLT PET/CT)
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 3
- Registration Number
- NCT03121599
- Locations
- 🇶🇦
National Center for Cancer Care & Research (NCCCR), Doha, Qatar
18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia
Not Applicable
- Conditions
- Essential ThrombocythemiaPrimary Myelofibrosis, Prefibrotic StagePrimary Myelofibrosis, Fibrotic Stage
- Interventions
- Device: Diagnostic (18F-FLT PET/CT)
- First Posted Date
- 2017-04-17
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT03116542
- Locations
- 🇶🇦
National Center for Cancer Care & Research (NCCCR), Doha, Qatar
High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue
Not Applicable
- Conditions
- BronchiolitisRespiratory Syncytial Virus (RSV)
- Interventions
- Device: Heated Humidified High Flow Nasal CannulaDevice: Standard Therapy (Low Flow Nasal Cannula)
- First Posted Date
- 2017-03-29
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 350
- Registration Number
- NCT03095495
- Locations
- 🇶🇦
Alsadd Pediatric Emergency Center, Doha, Qatar
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Phase 3
Terminated
- Conditions
- Chronic Myeloid Leukemia - Chronic Phase
- Interventions
- First Posted Date
- 2017-03-14
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 10
- Registration Number
- NCT03079505
- Locations
- 🇶🇦
National Center for Cancer Care & Research (NCCCR), Doha, Qatar
© Copyright 2025. All Rights Reserved by MedPath